These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19369)

  • 1. The possible role of dopamine in phenothiazine-induced hypothermia in rats: an application to DA hypothesis of schizophrenia.
    Yehuda S; Frommer R
    Int J Neurosci; 1977; 7(2):67-72. PubMed ID: 19369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of d-amphetamine- or chlorpromazine-induced hypothermia by beta-endorphin, MIF-I, and alpha-MSH: mediation by the dopaminergic system.
    Yehuda S; Carasso RL
    Peptides; 1982; 3(2):105-10. PubMed ID: 6124951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the hypothermic effects of methylphenidate and d-amphetamine.
    Yehuda S; Ben-Uriah Y; Carasso RL
    Int J Neurosci; 1981; 13(2-3):117-20. PubMed ID: 7239782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of neuroleptic and serotonergic drugs on amphetamine-induced hypothermia in mice.
    Boschi G; Launay N
    Neuropharmacology; 1985 Feb; 24(2):117-22. PubMed ID: 2859540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
    Ichikawa J; Meltzer HY
    Brain Res; 1992 Mar; 574(1-2):98-104. PubMed ID: 1379112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of chronic neuroleptic administration on cerebral dopamine receptor function.
    Rupniak MN; Jenner P; Marsden CD
    Life Sci; 1983 May; 32(20):2289-311. PubMed ID: 6133203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic haloperidol-amphetamine interactions and mesolimbic dopamine.
    Lynch MR; Kuhn HG; Carey RJ
    Neuropsychobiology; 1988; 19(2):97-103. PubMed ID: 3226530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antipsychotic drugs on the long-term effects of amphetamine on nigro-striatal dopamine neurons in iprindole-treated rats.
    Steranka LR
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):198-204. PubMed ID: 6145099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic D-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems.
    Robertson HA
    Brain Res; 1983 May; 267(1):179-82. PubMed ID: 6860944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supersensitivity of d-amphetamine-induced hyperthermia in rats following continuous treatment with neuroleptics.
    Norman AB; Wylie GL; Prince AK
    Eur J Pharmacol; 1987 Aug; 140(3):349-51. PubMed ID: 2888671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. d-Amphetamine and gamma-butyrolactone alteration of dopamine synthesis in the terminals of nigrostriatal and mesolimbic neurons. Possible role of various autoreceptor sensitivities.
    Demarest KT; Lawson-Wendling KL; Moore KE
    Biochem Pharmacol; 1983 Feb; 32(4):691-7. PubMed ID: 6403019
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of neuroleptics and of combinations of d-amphetamine and neuroleptics on 3H-dopamine uptake by homogenates from rat striatum.
    Del Rio J; Madroñal J
    Eur J Pharmacol; 1976 Oct; 39(2):267-74. PubMed ID: 976322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of d-amphetamine, beta-phenylethylamine, cocaine and methylphenidate on the rate of dopamine synthesis in terminals of nigrostriatal and mesolimbic neurons and on the efflux of dopamine metabolites into cerebroventricular perfusates of rats.
    Nielsen JA; Chapin DS; Moore KE
    Life Sci; 1983 Nov; 33(19):1899-907. PubMed ID: 6645784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of neuroleptics on release of 3H-dopamine from slices of rat corpus striatum.
    Dismukes K; Mulder AH
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(1):23-9. PubMed ID: 16224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic drugs, neurotransmitters, and schizophrenia.
    Carlsson A
    Am J Psychiatry; 1978 Feb; 135(2):165-73. PubMed ID: 23684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenothiazines Enhance Mild Hypothermia-induced Neuroprotection via PI3K/Akt Regulation in Experimental Stroke.
    An H; Duan Y; Wu D; Yip J; Elmadhoun O; Wright JC; Shi W; Liu K; He X; Shi J; Jiang F; Ji X; Ding Y
    Sci Rep; 2017 Aug; 7(1):7469. PubMed ID: 28785051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors.
    Walters JR; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 296(1):5-14. PubMed ID: 13315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine.
    Spyraki C; Fibiger HC
    Eur J Pharmacol; 1981 Sep; 74(2-3):195-206. PubMed ID: 7198991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.
    Innis RB; Malison RT; al-Tikriti M; Hoffer PB; Sybirska EH; Seibyl JP; Zoghbi SS; Baldwin RM; Laruelle M; Smith EO
    Synapse; 1992 Mar; 10(3):177-84. PubMed ID: 1532675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.